Fortis Malar Hospitals Ltd

Fortis Malar Hospitals Ltd

₹ 62.0 -0.08%
25 Jul - close price
About

Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of providing health care & medical services[1]

Key Points

Business Overview:[1][2]
Company is a part of Fortis Group, being subsidiary of Fortis Hospitals Limited and Intermediate Holding Company of Fortis Healthcare Ltd. The Hospital building is owned by a fellow subsidiary, Fortis Health Management Limited. Company has entered into Hospital and Medical Services Agreement
with FHML for rendering of medical and healthcare services at the hospital building

  • Market Cap 116 Cr.
  • Current Price 62.0
  • High / Low 108 / 44.0
  • Stock P/E
  • Book Value 58.3
  • Dividend Yield 68.6 %
  • ROCE -1.54 %
  • ROE -6.99 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 1.06 times its book value
  • Stock is providing a good dividend yield of 68.6%.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -16.4% over past five years.
  • Company has a low return on equity of -12.6% over last 3 years.
  • Earnings include an other income of Rs.66.0 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
23.18 19.93 20.45 22.62 20.10 23.29 21.90 20.66 17.76 18.15 17.58 5.52 0.00
22.28 20.93 20.19 19.34 20.12 21.01 20.31 19.93 18.27 18.23 18.66 5.04 0.88
Operating Profit 0.90 -1.00 0.26 3.28 -0.02 2.28 1.59 0.73 -0.51 -0.08 -1.08 0.48 -0.88
OPM % 3.88% -5.02% 1.27% 14.50% -0.10% 9.79% 7.26% 3.53% -2.87% -0.44% -6.14% 8.70%
2.04 1.97 1.76 1.56 1.62 1.49 1.51 1.94 1.59 2.29 1.24 61.68 0.83
Interest 1.72 1.67 1.61 1.55 1.55 1.61 1.49 1.42 1.35 1.30 1.26 0.39 0.01
Depreciation 3.08 3.09 3.12 3.24 3.02 2.91 2.78 3.44 2.67 2.72 2.91 1.06 0.00
Profit before tax -1.86 -3.79 -2.71 0.05 -2.97 -0.75 -1.17 -2.19 -2.94 -1.81 -4.01 60.71 -0.06
Tax % -27.42% 0.00% 0.00% 1,020.00% 0.00% 485.33% 0.00% 219.63% 0.00% 0.00% 0.00% 7.69% 0.00%
-1.35 -3.79 -2.71 -0.46 -2.97 -4.39 -1.17 -7.01 -2.94 -1.81 -4.01 56.04 -0.06
EPS in Rs -0.72 -2.02 -1.45 -0.25 -1.58 -2.34 -0.62 -3.74 -1.57 -0.97 -2.14 29.90 -0.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
98 108 118 130 141 149 145 112 69 86 86 59 41
86 99 110 123 140 147 147 115 76 83 81 60 43
Operating Profit 11 9 8 6 1 2 -2 -3 -6 3 5 -1 -2
OPM % 12% 8% 6% 5% 1% 1% -2% -2% -9% 4% 5% -2% -4%
46 7 7 7 8 8 10 11 15 7 7 67 66
Interest -2 0 1 0 0 0 1 8 7 7 6 4 3
Depreciation 2 2 3 3 4 4 4 13 13 13 12 9 7
Profit before tax 56 13 12 10 4 5 2 -12 -11 -8 -7 52 55
Tax % 24% 34% 34% 36% 30% 41% 27% -26% -30% 0% 119% 9%
43 9 8 6 3 3 2 -9 -8 -8 -16 47 50
EPS in Rs 23.22 4.60 4.12 3.35 1.51 1.68 0.93 -4.83 -4.27 -4.43 -8.29 25.23 26.76
Dividend Payout % 0% 11% 12% 15% 0% 0% 0% 0% 0% 0% 0% 169%
Compounded Sales Growth
10 Years: -6%
5 Years: -16%
3 Years: -5%
TTM: -51%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 17%
TTM: 79%
Stock Price CAGR
10 Years: 5%
5 Years: 4%
3 Years: -1%
1 Year: 7%
Return on Equity
10 Years: -3%
5 Years: -13%
3 Years: -13%
Last Year: -7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 19 19 19 19 19 19 19 19 19 19 19 19
Reserves 58 66 72 78 80 83 85 76 68 59 43 90
0 0 0 0 0 0 0 64 57 53 46 0
13 16 19 32 31 46 45 33 23 27 27 6
Total Liabilities 90 101 110 129 129 147 148 191 167 159 136 115
17 18 18 24 25 24 22 81 69 58 47 0
CWIP 0 1 1 0 1 1 1 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
72 82 92 104 104 123 126 110 98 101 88 115
Total Assets 90 101 110 129 129 147 148 191 167 159 136 115

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-64 6 4 11 -10 10 -16 -0 -1 7 6 -7
72 -1 5 -22 15 -2 6 48 -28 8 0 120
-7 -1 0 -1 -1 0 0 -12 -7 -10 -13 -11
Net Cash Flow 2 3 9 -12 4 8 -9 36 -36 5 -7 102

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 12 13 13 17 14 15 24 12 11 9 14 0
Inventory Days 4 13 35 28 22 18 22 42 40 32 0
Days Payable 153 169 286 173 276 255 323 375 429 584
Cash Conversion Cycle 12 -136 -143 -234 -130 -239 -212 -289 -322 -379 -539 0
Working Capital Days 213 189 166 127 150 130 154 -38 134 52 219 4
ROCE % 17% 17% 14% 12% 5% 6% 3% -3% -7% -1% -1% -2%

Shareholding Pattern

Numbers in percentages

6 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71% 62.71%
0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%
37.22% 37.22% 37.22% 37.22% 37.23% 37.23% 37.23% 37.23% 37.23% 37.23% 37.23% 37.22%
No. of Shareholders 9,4229,3659,6889,5789,5208,7728,7318,6518,6309,79010,21316,452

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents